Hypoactive Sexual Desire Disorder (HSDD)

Also known as: Hypoactive sexual desire disorder / Hypoactive Sexual Desire Disorder(HSDD) / Decreased sexual desire / Sexual desire decreased / Sexual arousal decreased / Sexual feeling decreased / Decreased Libido / Libido decreased / Low libido

DrugDrug NameDrug Description
DB11653BremelanotideBremelanotide is indicated to treat premenopausal women with hypoactive sexual desire disorder that is not due to a medical or psychiatric condition, problems with the relationship, or the effects of...
DB04908FlibanserinA 5-HT receptor modulator used for the treatment of selected premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD).
DrugDrug NamePhaseStatusCount
DB00624Testosterone1Terminated1
DB11653Bremelanotide2Completed1
DB01156Bupropion2Completed1
DB00490Buspirone2Completed2
DB01381Ginkgo biloba2Completed1
DB00203Sildenafil2Completed1
DB00624Testosterone2Completed3
DB11653Bremelanotide3Completed2
DB01708Prasterone3Completed1
DB01708Prasterone3Withdrawn1
DB00624Testosterone3Completed12
DB11653Bremelanotide4Recruiting1
DB04908Flibanserin4Terminated1
DB00624Testosterone4Completed1
DB00783EstradiolNot AvailableCompleted1
DB04908FlibanserinNot AvailableRecruiting1
DB01708PrasteroneNot AvailableUnknown Status1
DB00624TestosteroneNot AvailableCompleted1